TY - JOUR
AU - R. K. Landis
AU - B. D. Stein
AU - A. W. Dick
AU - B. A. Griffin
AU - B. K. Saloner
AU - M. Terplan
AU - L. J. Faherty
A1 - 
AB - We described Medicaid-insured women by receipt of perinatal opioid use disorder (OUD) treatment; and trends and disparities in treatment. Using 2007 to 2012 Medicaid Analytic eXtract data from 45 states and D.C., we identified deliveries among women with OUD. Regressions modeled the association between patient characteristics and receipt of any OUD treatment, medication for OUD (MOUD), and counseling alone during the perinatal period. Rates of any OUD treatment and MOUD for women with perinatal OUD increased over the study period, but trends differed by subgroup. Compared with non-Hispanic White women, Black and American Indian/Alaskan Native (AI/AN) women were less likely to receive any OUD treatment, and Black women were less likely to receive MOUD. Over time, the disparity in receipt of MOUD between Black and White women increased. Overall gains in OUD treatment were driven by improvements in perinatal OUD care for White women and obscured disparities for Black and AI/AN women.
AD - RAND Corporation, Arlington, VA, USA.; RAND Corporation, Pittsburgh, PA, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Friends Research Institute, Baltimore, MD, USA.; RAND Corporation, Boston, MA, USA.; Maine Medical Center, Portland, ME, USA.
AN - 38160405
BT - Med Care Res Rev
C5 - Opioids & Substance Use; Healthcare Disparities; Financing & Sustainability
CP - 2
DA - Apr
DO - 10.1177/10775587231216515
DP - NLM
ET - 20231231
IS - 2
JF - Med Care Res Rev
LA - eng
N2 - We described Medicaid-insured women by receipt of perinatal opioid use disorder (OUD) treatment; and trends and disparities in treatment. Using 2007 to 2012 Medicaid Analytic eXtract data from 45 states and D.C., we identified deliveries among women with OUD. Regressions modeled the association between patient characteristics and receipt of any OUD treatment, medication for OUD (MOUD), and counseling alone during the perinatal period. Rates of any OUD treatment and MOUD for women with perinatal OUD increased over the study period, but trends differed by subgroup. Compared with non-Hispanic White women, Black and American Indian/Alaskan Native (AI/AN) women were less likely to receive any OUD treatment, and Black women were less likely to receive MOUD. Over time, the disparity in receipt of MOUD between Black and White women increased. Overall gains in OUD treatment were driven by improvements in perinatal OUD care for White women and obscured disparities for Black and AI/AN women.
PY - 2024
SN - 1077-5587
SP - 145
EP - 155+
ST - Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012
T1 - Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012
T2 - Med Care Res Rev
TI - Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012
U1 - Opioids & Substance Use; Healthcare Disparities; Financing & Sustainability
U3 - 10.1177/10775587231216515
VL - 81
VO - 1077-5587
Y1 - 2024
ER -